Increasing herd immunity with influenza revaccination.
Identifieur interne : 000144 ( Main/Exploration ); précédent : 000143; suivant : 000145Increasing herd immunity with influenza revaccination.
Auteurs : E Q Mooring [États-Unis] ; S. Bansal [États-Unis]Source :
- Epidemiology and infection [ 1469-4409 ] ; 2016.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Colombie-Britannique, Enfant, Enfant d'âge préscolaire, Grippe humaine (), Grippe humaine (immunologie), Humains, Immunité de groupe, Jeune adulte, Modèles théoriques, Nourrisson, Nouveau-né, Rappel de vaccin, Saisons, Santé publique (tendances), Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccins antigrippaux (administration et posologie), Villes, Virus de la grippe A (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Grippe humaine, Virus de la grippe A.
- tendances : Santé publique.
- Adolescent, Adulte, Adulte d'âge moyen, Colombie-Britannique, Enfant, Enfant d'âge préscolaire, Grippe humaine, Humains, Immunité de groupe, Jeune adulte, Modèles théoriques, Nourrisson, Nouveau-né, Rappel de vaccin, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Villes.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, British Columbia, Child, Child, Preschool, Cities, Humans, Immunity, Herd, Immunization, Secondary, Infant, Infant, Newborn, Influenza A virus (immunology), Influenza Vaccines (administration & dosage), Influenza, Human (immunology), Influenza, Human (prevention & control), Middle Aged, Models, Theoretical, Public Health (trends), Seasons, Young Adult.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- immunology : Influenza A virus, Influenza, Human.
- prevention & control : Influenza, Human.
- trends : Public Health.
- Adolescent, Adult, Aged, Aged, 80 and over, British Columbia, Child, Child, Preschool, Cities, Humans, Immunity, Herd, Immunization, Secondary, Infant, Infant, Newborn, Middle Aged, Models, Theoretical, Seasons, Young Adult.
Abstract
Seasonal influenza is a significant public health concern globally. While influenza vaccines are the single most effective intervention to reduce influenza morbidity and mortality, there is considerable debate surrounding the merits and consequences of repeated seasonal vaccination. Here, we describe a two-season influenza epidemic contact network model and use it to demonstrate that increasing the level of continuity in vaccination across seasons reduces the burden on public health. We show that revaccination reduces the influenza attack rate not only because it reduces the overall number of susceptible individuals, but also because it better protects highly connected individuals, who would otherwise make a disproportionately large contribution to influenza transmission. We also demonstrate that our results hold on an empirical contact network, in the presence of assortativity in vaccination status, and are robust for a range of vaccine coverage and efficacy levels. Our work contributes a population-level perspective to debates about the merits of repeated influenza vaccination and advocates for public health policy to incorporate individual vaccine histories.
DOI: 10.1017/S0950268815002253
PubMed: 26482721
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increasing herd immunity with influenza revaccination.</title><author><name sortKey="Mooring, E Q" sort="Mooring, E Q" uniqKey="Mooring E" first="E Q" last="Mooring">E Q Mooring</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biology,Georgetown University,Washington,DC,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biology,Georgetown University,Washington,DC</wicri:regionArea><placeName><region type="state">District de Columbia</region></placeName></affiliation></author><author><name sortKey="Bansal, S" sort="Bansal, S" uniqKey="Bansal S" first="S" last="Bansal">S. Bansal</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biology,Georgetown University,Washington,DC,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biology,Georgetown University,Washington,DC</wicri:regionArea><placeName><region type="state">District de Columbia</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26482721</idno><idno type="pmid">26482721</idno><idno type="doi">10.1017/S0950268815002253</idno><idno type="wicri:Area/Main/Corpus">000175</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000175</idno><idno type="wicri:Area/Main/Curation">000175</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000175</idno><idno type="wicri:Area/Main/Exploration">000175</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Increasing herd immunity with influenza revaccination.</title><author><name sortKey="Mooring, E Q" sort="Mooring, E Q" uniqKey="Mooring E" first="E Q" last="Mooring">E Q Mooring</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biology,Georgetown University,Washington,DC,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biology,Georgetown University,Washington,DC</wicri:regionArea><placeName><region type="state">District de Columbia</region></placeName></affiliation></author><author><name sortKey="Bansal, S" sort="Bansal, S" uniqKey="Bansal S" first="S" last="Bansal">S. Bansal</name><affiliation wicri:level="2"><nlm:affiliation>Department of Biology,Georgetown University,Washington,DC,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biology,Georgetown University,Washington,DC</wicri:regionArea><placeName><region type="state">District de Columbia</region></placeName></affiliation></author></analytic><series><title level="j">Epidemiology and infection</title><idno type="eISSN">1469-4409</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>British Columbia</term><term>Child</term><term>Child, Preschool</term><term>Cities</term><term>Humans</term><term>Immunity, Herd</term><term>Immunization, Secondary</term><term>Infant</term><term>Infant, Newborn</term><term>Influenza A virus (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Middle Aged</term><term>Models, Theoretical</term><term>Public Health (trends)</term><term>Seasons</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Colombie-Britannique</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Humains</term><term>Immunité de groupe</term><term>Jeune adulte</term><term>Modèles théoriques</term><term>Nourrisson</term><term>Nouveau-né</term><term>Rappel de vaccin</term><term>Saisons</term><term>Santé publique (tendances)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Villes</term><term>Virus de la grippe A (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Santé publique</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Public Health</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>British Columbia</term><term>Child</term><term>Child, Preschool</term><term>Cities</term><term>Humans</term><term>Immunity, Herd</term><term>Immunization, Secondary</term><term>Infant</term><term>Infant, Newborn</term><term>Middle Aged</term><term>Models, Theoretical</term><term>Seasons</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Colombie-Britannique</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Grippe humaine</term><term>Humains</term><term>Immunité de groupe</term><term>Jeune adulte</term><term>Modèles théoriques</term><term>Nourrisson</term><term>Nouveau-né</term><term>Rappel de vaccin</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Villes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Seasonal influenza is a significant public health concern globally. While influenza vaccines are the single most effective intervention to reduce influenza morbidity and mortality, there is considerable debate surrounding the merits and consequences of repeated seasonal vaccination. Here, we describe a two-season influenza epidemic contact network model and use it to demonstrate that increasing the level of continuity in vaccination across seasons reduces the burden on public health. We show that revaccination reduces the influenza attack rate not only because it reduces the overall number of susceptible individuals, but also because it better protects highly connected individuals, who would otherwise make a disproportionately large contribution to influenza transmission. We also demonstrate that our results hold on an empirical contact network, in the presence of assortativity in vaccination status, and are robust for a range of vaccine coverage and efficacy levels. Our work contributes a population-level perspective to debates about the merits of repeated influenza vaccination and advocates for public health policy to incorporate individual vaccine histories. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26482721</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol. Infect.</ISOAbbreviation></Journal><ArticleTitle>Increasing herd immunity with influenza revaccination.</ArticleTitle><Pagination><MedlinePgn>1267-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268815002253</ELocationID><Abstract><AbstractText>Seasonal influenza is a significant public health concern globally. While influenza vaccines are the single most effective intervention to reduce influenza morbidity and mortality, there is considerable debate surrounding the merits and consequences of repeated seasonal vaccination. Here, we describe a two-season influenza epidemic contact network model and use it to demonstrate that increasing the level of continuity in vaccination across seasons reduces the burden on public health. We show that revaccination reduces the influenza attack rate not only because it reduces the overall number of susceptible individuals, but also because it better protects highly connected individuals, who would otherwise make a disproportionately large contribution to influenza transmission. We also demonstrate that our results hold on an empirical contact network, in the presence of assortativity in vaccination status, and are robust for a range of vaccine coverage and efficacy levels. Our work contributes a population-level perspective to debates about the merits of repeated influenza vaccination and advocates for public health policy to incorporate individual vaccine histories. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mooring</LastName><ForeName>E Q</ForeName><Initials>EQ</Initials><AffiliationInfo><Affiliation>Department of Biology,Georgetown University,Washington,DC,USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology,Georgetown University,Washington,DC,USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001955" MajorTopicYN="N">British Columbia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002947" MajorTopicYN="N">Cities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032521" MajorTopicYN="Y">Immunity, Herd</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="Y">Immunization, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disease control</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">influenza (seasonal)</Keyword><Keyword MajorTopicYN="N">mathematical modelling</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26482721</ArticleId><ArticleId IdType="pii">S0950268815002253</ArticleId><ArticleId IdType="doi">10.1017/S0950268815002253</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>District de Columbia</li></region></list><tree><country name="États-Unis"><region name="District de Columbia"><name sortKey="Mooring, E Q" sort="Mooring, E Q" uniqKey="Mooring E" first="E Q" last="Mooring">E Q Mooring</name></region><name sortKey="Bansal, S" sort="Bansal, S" uniqKey="Bansal S" first="S" last="Bansal">S. Bansal</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000144 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000144 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26482721
|texte= Increasing herd immunity with influenza revaccination.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26482721" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |